Orchestra BioMed
OBIO
OBIO
39 hedge funds and large institutions have $75.5M invested in Orchestra BioMed in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 3 closing their positions.
Holders
39
Holders Change
+17
Holders Change %
+77.27%
% of All Funds
0.62%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
20
Increased
10
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RI
1
RTW Investments
New York
|
$39.3M |
| 2 |
2
BlackRock
New York
|
$5.99M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$993K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$1.35M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$1.36M |
